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Abstract
Background
Community based breastfeeding promotion programmes have been shown to be effective in
increasing breastfeeding prevalence. However, there is limited data on the cost-effectiveness
of these programmes in sub-Saharan Africa. This paper evaluates the cost-effectiveness of a
breastfeeding promotion intervention targeting mothers and their 0 to 6 month old children.
Methods
Data were obtained from a community randomized trial conducted in Uganda between 2006–
2008, and supplemented with evidence from several studies in sub-Saharan Africa. In the
trial, peer counselling was offered to women in intervention clusters. In the control and inter-
vention clusters, women could access standard health facility breastfeeding promotion ser-
vices (HFP). Thus, twomethods of breastfeeding promotion were compared: community
based peer counselling (in addition to HFP) and standard HFP alone. A Markov model was
used to calculate incremental cost-effectiveness ratios between the two strategies. The
model estimated changes in breastfeeding prevalence and disability adjusted life years.
Costs were estimated from a provider perspective. Uncertainty around the results was char-
acterized using one-way sensitivity analyses and a probabilistic sensitivity analysis.
Findings
Peer counselling more than doubled the breastfeeding prevalence as reported by mothers,
but there was no observable impact on diarrhoea prevalence. Estimated incremental cost-
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effectiveness ratios were US$68 per month of exclusive or predominant breastfeeding and
U$11,353 per disability adjusted life year (DALY) averted. The findings were robust to
parameter variations in the sensitivity analyses
Conclusions
Our strategy to promote community based peer counselling is unlikely to be cost-effective in
reducing diarrhoea prevalence and mortality in Uganda, because its cost per DALY averted
far exceeds the commonly assumed willingness-to-pay threshold of three times Uganda’s
GDP per capita (US$1653). However, since the intervention significantly increases preva-
lence of exclusive or predominant breastfeeding, it could be adopted in Uganda if benefits
other than reducing the occurrence of diarrhoea are believed to be important.
Introduction
Breastfeeding is vital to child survival, as it provides protection against diseases, including diar-
rhoea and acute respiratory infections [1–3]. Breastfeeding promotion is therefore central to
infant health promotion in low and middle income countries (LMICS). The World Health
Organisation (WHO) recommends exclusive breastfeeding (EBF) for the first six months [4].
Though breastfeeding is widespread in most LMICS, EBF is less common [5]. Globally, early
initiation of breastfeeding averages about 43%, and EBF at six months is close to 39%; only a
third of African children below six months are exclusively breastfed [6]. In Uganda, EBF at six
months was 63% in 2011 [7].
Interventions to educate mothers on the importance of breastfeeding can increase EBF prev-
alence [8]. EBF promotion is mainly undertaken at health facilities, through initiatives such as
the Baby Friendly Hospital Initiative and the Integrated Management of Childhood Illness [9,
10]. Community-based strategies are also reported to be efficacious [11–14]. We previously
reported the results of a trial (PROMISE-EBF), where peer counselling substantially increased
breastfeeding prevalence [11].
Community-based breastfeeding initiatives are rarely undertaken on a large scale in sub-
Saharan Africa, and there is limited data on economic impact. In earlier publications, we pre-
sented the costs of breastfeeding promotion in Uganda [15] and South Africa [16]. The only
other cost analysis of a breastfeeding intervention in sub-Saharan Africa [17] showed that com-
munity-based peer counselling could increase EBF prevalence at five months by over 70%;
costs ranged from US$23 to US$126 per month of EBF [17].
In this paper, we estimate the cost-effectiveness of community-based peer counselling to
promote EBF, for the reduction of diarrhoeal morbidity and mortality in Uganda, compared to
facility-based breastfeeding promotion. We assess the additional benefits that can be gained
from implementing a community-based breastfeeding strategy, and the associated incremental
costs. This economic evaluation is based on the cluster randomised PROMISE-EBF trial, which
was undertaken in Uganda between January 2006 and June 2008. The findings of this study
can potentially influence investments to improve breastfeeding promotion interventions in
Uganda.
The PROMISE-EBF Trial
PROMISE-EBF was a multi-site cluster-randomised trial conducted in Burkina Faso, South
Africa, Uganda, and Zambia. The aim of the study was to assess the impact of individual
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home-based peer counselling to promote exclusive breastfeeding for 6 months after birth. The
PROMISE-EBF trial is registered with ClinicalTrials.gov, number NCT00397150. The protocol
for this is available as supporting information (see the trial protocol in S1 Protocol). The trial
design and results have been published elsewhere [11], and are summarised in this paper.
Study setting and design
In Uganda, the study was undertaken in Mbale district, with a population of about 400,000
[18]. The unit of randomization were clusters of villages with an average of 1,000 inhabitants,
with a birth rate of approximately 35 per cluster. Twenty-four clusters in Mbale district were
selected and randomized 1:1 to either control or intervention groups, based on similarities in
terms of location, urban-rural set ups and socio-economic status. Women in intervention clus-
ters received home-based individual peer counselling from lay counsellors, to encourage EBF
for six month. The women received five visits, once in the third trimester and during the first
week of birth, and in weeks four, seven and ten. Extra visits were offered to mothers with
breastfeeding problems or if the mother or counsellor for other reasons deemed it necessary. In
the control group, women received standard care provided at public health facilities.
Selection of peer supporters
Sensitization workshops and meetings aimed at introducing the project to community leaders
were held prior to commencement of the trial. The community leaders facilitated the mobilisa-
tion of local women to work as peer counsellors on the project. Twelve women were selected as
peer supporters, one in each cluster.
Data collection
Study questionnaires were developed and adapted from previous work undertaken in the coun-
tries that participated in the trial [19–22], and were piloted in Uganda in 2005 [23]. Data were
gathered between 2006 and 2008 in the mothers’ homes by trained data gatherers. The ques-
tionnaire was administered at 3, 6, 12 and 24 weeks postpartum, to determine their children’s
well-being, including the breastfeeding and diarrhoea status.
Ethics considerations
Study approval was obtained from Faculty of Medicine, Makerere University; Research and
Ethics Committee, Uganda National Council for Science and Technology; and regional com-
mittees for Medical and Health Research Ethics in Norway. Women provided verbal informed
consent in the peer counselling programme and signed or thumb-printed informed consent
during data gathering. The age eligibility was 15 years and older. Mothers younger than 18
years had witnessed informed consent.
Data analysis
The primary trial outcome trial was EBF prevalence and diarrhoea at 12 and 24 weeks, as
reported by mothers. Current breastfeeding was assessed at all post-partum visits using a moth-
er’s 24-hour and 7-day recall. These recall periods are widely used [7] and have been shown to
provide reliable estimates [23, 24]. Children who did not receive any other food or liquids
other than breastmilk were deemed to be exclusively breastfed, even if they had been
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administered drugs. Diarrhoea prevalence was also based on the mothers’ reports and was
assessed using a 2-week recall [11], considering that shorter recall periods could provide under-
estimates when symptoms fluctuate from day-to-day [25]. Data analysis was done on an inten-
tion to treat basis and included all mother-infant pairs in the analysis, thus all missing, loss to
follow-up and deaths were recoded as non-events (not having EBF or diarrhoea). Analyses
excluding cases without valid results were also provided [11].
Study outcomes
A total of 329 mother-infant pairs in the intervention and 368 in the control group were fol-
lowed up until 24 weeks after birth (Fig 1). At 12 weeks, EBF prevalence (24 hour recall) in the
intervention group was 82%, compared to 44% in the control group, with a prevalence ratio
(confidence interval) of 1.89 (1.70–2.11) [11]. The 12 week diarrhoea prevalence was 10% in
the intervention and 9% in the control group, prevalence ratio 1.13 (0.81–1.59). Other factors,
including socio-economic status, maternal age, parity, mothers’ education and marital status
were fairly evenly distributed between intervention and control groups, and were not deemed
to affect breastfeeding and diarrhoea outcomes [11].
Methods for the Economic Evaluation
An economic model based on the PROMISE-EBF trial was created in order to estimate the
cost-effectiveness of using peer counselling to promote exclusive breastfeeding. Because some
of the data needed to populate the model, such as hospitalisation rates and disease costs, were
not captured during the trial, this was supplemented by evidence from the literature. The
CHEERS checklist was used to guide reporting (see the checklist in S1 Checklist).
Comparators in the economic evaluation
The economic evaluation compares two breastfeeding promotion strategies, based on the con-
trol and intervention groups in the trial: 1) community-based peer counselling conducted
alongside breastfeeding promotion in facility-based maternal and child health services, includ-
ing antenatal and postnatal services (herein after referred to as peer counselling); and 2) breast-
feeding promotion in facility-based maternal and child health services only (herein after
referred to as health facility breastfeeding promotion—HFP). This followed the set-up in the
PROMISE-EBF trial, where peer counselling was offered to pregnant women and mothers of
newborns, while in both control and intervention clusters, women could access standard health
facility services.
Facility-based breastfeeding promotion is often done at antenatal and postnatal services.
Many facility-based maternal and child health packages provide health advice and other ser-
vices for improved maternal and child health. Women are encouraged to attend antenatal clin-
ics at least once during pregnancy and other under-five services after birth. Over 90% of
pregnant women in Uganda access antenatal care (ANC) at least once before or after delivery,
and over 50% attend postnatal services [7]. PROMISE-EBF did not assess the quantity or qual-
ity of facility-based services, but parallel research within our study group has described current
practices in the study setting [26].
Cost-Effectiveness of Breastfeeding Promotion
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Fig 1. Uganda PROMISE-EBF trial profile.
doi:10.1371/journal.pone.0142718.g001
Cost-Effectiveness of Breastfeeding Promotion
PLOS ONE | DOI:10.1371/journal.pone.0142718 November 30, 2015 5 / 18
The economic model
A decision tree with a state Markov model was used to depict breastfeeding promotion and the
associated feeding patterns in the first six months of life (Fig 2). The model predicts feeding
patterns and children can have one of two options: exclusive or predominant breastfeeding
(EBF/PBF) and mixed or replacement feeding (MF/RF), see Box 1 for definitions. The merging
of EBF and PBF was done because few studies indicate clear differences in health outcomes
between EBF and PBF [11, 27]. MF and RF were merged because only 0.3% of the children in
the PROMISE-EBF trial received replacement feeding. In the model, children were allowed to
move both ways between feeding states. This was done to reflect the findings of the PROMI-
SE-EBF trial, which showed that mothers tended to periodically switch between EBF/PBF and
MF [28]. This might be the case, since the definition of EBF/PBF was based on shorter periods
(24-hours and 1-week recall), which may allow for more frequent fluctuations and may under-
represent usual practice [29].
Fig 2. Decisionmodel of cost-effectiveness analysis for peer counselling vs HFP.
doi:10.1371/journal.pone.0142718.g002
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At each feeding state a decision tree model depicts three health scenarios: sick (diarrhoea),
well (no diarrhoea) and dead. The diarrhoea state could either be severe, in which case the
child would be hospitalised, moderate–requiring outpatient treatment, or mild–requiring no
treatment. Probabilities of diarrhoea and mortality were assumed to depend on the feeding
practice, i.e. whether a child belonged to the EBF/PBF or MF/RF pattern.
The model had monthly cycles, terminating at six months, based on the PROMISE-EBF
trial. It was based on the hypothesis that additional breastfeeding promotion increases EBF/
PBF prevalence, which in turn could affect morbidity and mortality.
Model parameters
EBF and diarrhoea prevalence. In the PROMISE-EBF trial, mothers were followed up for
six months, and a questionnaire was administered at 3, 6, 12 and 24 weeks postpartum. These
data were used to estimate feeding and diarrhoea state transition probabilities.
Feeding state transition probabilities were estimated using parametric survival models [30]
of EBF/PBF duration (Table 1) [28]. A multiple events model was used to estimate survival.
The event was cessation of EBF/PBF, a time dependent variable indicating the age at which
EBF/PBF was stopped. Cases were censored if respondents were lost to follow-up, missed the
last valid interview, or continued EBF/PBF beyond six months.
Probabilities of diarrhoea events (sick or well) were estimated using longitudinal/panel
methods in STATA. The aim was to assess diarrhoea morbidity in infants during the six month
follow-up. We estimated four transition probabilities between two states (sick and well) as
shown in Table 2. The events were dependent on a child’s feeding state.
Hospitalisation for diarrhoea. The PROMISE-EBF trial did not collect data on diarrhoea
hospitalisation. We based our assumptions on diarrhoea hospitalisation on a systematic review
of breastfeeding and the risk of diarrhoea and diarrheal death [31]. This study reviewed litera-
ture published from 1980 to 2009 on suboptimal breastfeeding and the associated diarrhoea
morbidity and mortality. Random effects meta-analyses were conducted on 18 studies, to gen-
erate pooled relative risks of diarrhoea hospitalisation and death. The estimated relative risk
(95% confidence interval) of diarrhoea hospitalisation was 2.3 (0.08–6.55) for predominantly,
Box 1. Definitions of infant feeding patterns.
Exclusive breastfeeding is when only breast milk is given to the child, except for medi-
cines, vitamins or mineral supplements.
Predominant breastfeeding is when breast milk is nutritionally dominant while
given in addition to water-based fluids including fruit juices, tea without milk or oral
rehydration salts.
Complementary feeding including breast milk (partial breastfeeding or mixed
feeding): These terms are used to describe when non-human milk, semi-solids or other
solids are given to the child in addition to breast milk. The term mixed feeding does nor-
mally refer to the feeding practice specified above during the first half of infancy (under
6 months old).
Replacement feeding is defined as the feeding strategy when breastfeeding has been
stopped, or if the child never has been given any breast milk. Exclusive replacement feed-
ing was defined as when never having given any breast milk.
Cost-Effectiveness of Breastfeeding Promotion
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4.4 (1.75–13.84) for partially and 19.5 (6.13–33.86) for not breastfed infants 0–5 months of age,
compared to those exclusively breastfed (Table 3).
Cost estimates. Costs were assessed from a provider perspective (Table 3), mainly because
the cost analysis done on the PROMISE-EBF trial was retrospective and only costs from project
accounts could be obtained [15].
Costs of peer counselling were estimated in the PROMISE-EBF trial. The structure of the
trial could be broken in four basic functions: administration; peer supervision and coordina-
tion; peer support; and recruitment (done by recruiters, who recruited mothers into the trial.
These were not peer supporters). We thus used an ingredients approach to costing, in order to
capture the different elements of the trial. Costs included capital items such as motor vehicles,
furniture and computers; and recurrent items such as salaries, fuel and rentals. Staff costs were
based on the local rates paid to employees in the trial. Peer supporters and recruiters were not
permanent members of staff. They were offered a token US$20 every month for their participa-
tion, a figure that was arrived at in a meeting with peer supporters, where they agreed on this
as adequate compensation for their time. Intervention start-up costs, as well as costs of training
and retraining of peer supporters were also included in the analysis. Detailed descriptions and
analyses of the costs of the PROMISE-EBF trial in Uganda are given elsewhere [15]. Annual
intervention costs were estimated to be US$56,308, and the cost per mother/infant pair (the
Table 1. Transition probabilities between feeding states in the PROMISE trial.
Months Control Intervention
α1 α2 α3 α4 α1 α2 α3 α4
1 0.67 0.33 0.82 0.18 0.81 0.19 0.93 0.07
2 0.73 0.27 0.76 0.24 0.89 0.11 0.85 0.15
3 0.74 0.26 0.72 0.28 0.91 0.09 0.79 0.21
4 0.75 0.25 0.70 0.30 0.92 0.08 0.75 0.25
5 0.76 0.24 0.68 0.32 0.92 0.08 0.71 0.29
6 0.77 0.23 0.66 0.34 0.93 0.07 0.68 0.32
Source: Chola et al. 2013. Infant feeding transitions among Ugandan children from the cluster-randomised trial PROMISE-EBF.
α1 = Probability of remaining in EBF/PBF; α2 = Probability of transitioning from EBF/PBF to MF/RF; α3 = Probability of remaining in MF/RF; α4 =
Probability of transitioning from MF/RF to EBF/PBF.
doi:10.1371/journal.pone.0142718.t001
Table 2. Transition probabilities between health states in the PROMISE-EBF trial.
β1 β2 β3 β4
Intervention group
EBF/PBF 0.08 0.88 0.12 0.92
MF/RF 0.07 0.86 0.14 0.93
Control group
EBF/PBF 0.06 0.64 0.36 0.94
MF/RF 0.10 0.71 0.29 0.90
β1 = Probability to be sick with diarrhoea in respective visit and continued diarrhoea in next visit; β2 =
Probability of diarrhoea in respective visit and changed to well (no diarrhoea) in next visit; β3 = Probability
of being well in respective visit, and continue in this state in next visit; β4 = Probability of well in respective
visit and sick in next visit.
doi:10.1371/journal.pone.0142718.t002
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output required in the economic model) was US$139 per year. The cost per visit was US$26
and the cost per week of EBF was estimated to be US$15 at 12 weeks post-partum.
Costs of HFP were not collected in the PROMISE-EBF trial, but were averaged from results
of two studies assessing maternal health services. Orach et al.[32] estimated an average cost of
antenatal and postnatal services ranging from US$2 to US$6 per child in three rural districts in
Uganda. Levin et al. [33] estimated an average antenatal and postnatal services cost between
US$2 to US$4 per child in Uganda. The average cost of US$3.6 was used in the model.
Diarrhoea treatment costs were also not collected in the trial. These were estimated form ad
hoc and PubMed searches for articles in English undertaken in the last decade on treatment
costs of diarrhoeal disease among infants in sub-Saharan Africa. The search words were costs,
cost analysis and diarrhoea. The criteria for selection were that studies presented results from a
provider perspective and provided costs for children less than five years. Studies were consid-
ered if costs were provided for outpatient, inpatient care or both. The search yielded 321 arti-
cles, whose abstracts were individually scrutinised. Fifteen articles were then selected for full
text assessment, out of which 3 were finally included from Kenya [34], Ghana [35] and Zambia
[36] (Table 3).
All costs were converted to 2007 prices using the local (specific country) consumer price
index, and then converted to US$ at the estimated exchange rate in 2007.
Effect measures. Two measures of effectiveness were calculated as follows:
1. Person months of EBF/PBF extracted from PROMISE-EBF data–estimated as the cumula-
tive months of EBF/PBF (MEBF). The mean duration of EBF/PBF estimated from the
Table 3. Base parameters used in the decisionmodel for exclusive breastfeeding promotion.
Parameter Estimate Source
Mortality rates Prevalence SA range
Control 3/1000 0.001–0.01 PROMISE-EBF
Intervention 8/1000 0.001–0.01 PROMISE-EBF
Hospitalisation Relative risk 95%CI
Predominantly breastfed 2.28 (0.08–6.55) Lamberti et al. (2011)
Partially breastfed 4.43 (1.75–13.84) Lamberti et al. (2011)
Not breastfed 14.40 (6.13–33.86) Lamberti et al. (2011)
Costs (US$) Mean SA range
Health facility promotion per child per year 3.60 2.20–6.43 Orach et al (2003)/Levin et al (2007)
Peer counselling per child per year 139 74–233 Chola et al (2011)
Hospitalised diarrhoea per case 95 65–134 Chola & Robberstad (2009), Aikins et al (2010), Tate et al (2009)
Non-hospitalised diarrhoea per case 9 3.80–26 Chola & Robberstad (2009), Aikins et al (2010), Tate et al (2009)
Other parameters Estimate SA range
Discount rate (r) 0.03 0–0.06
Life expectancy (years) 53 38–77 WHO (2014)
Diarrhoea disability weight Murray et al (2012)
Mild 0.061
Moderate 0.202
Severe 0.281
Age at onset (years) 0.1 Own assumption
Mean duration of diarrhoea (days) 7 Kirkwood et al (1991)
CI = Conﬁdence interval; RR = Relative risk; SA = Sensitivity analysis.
doi:10.1371/journal.pone.0142718.t003
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survival analysis was 1.5 in the control (HFP) and 3.5 months in the intervention (peer
counselling) group [28].
2. Disability adjusted life years (DALYs) due to diarrhoea–calculated as years of life lived with
disability (YLD), added to years of life lost (YLL) due to diarrhoea death. YLLs were calcu-
lated assuming a mean duration of seven days [37] average age at onset of 0.1 years, disabil-
ity weights of 0.061 for mild, 0.202 for moderate and 0.281 for severe diarrhoea [38] and life
expectancy at birth of 53 years [39]. Mortality estimates were made using PROMISE-EBF
data. The estimated all-cause mortality rates were 3/1000 children in the control and 8/1000
children in the intervention group [11]. DALYs were not age-weighted, but discounted at a
rate of 3% per annum.
Sensitivity analyses
Parameter uncertainty was assessed in one way sensitivity analyses. Life expectancy was varied
from 38 years (males in Sierra Leone) to 77 years (females in Libya) [39]. Discount rates for
both costs and outcomes were varied from 0% to 6% as recommended in the literature [40].
Disease costs were varied as follows: US$3.8 to US$26 for non-hospitalised and US$65 to US
$134 for hospitalised diarrhoea cases, based on the maximum and minimum ranges of costs
found in literature [34–36]. Diarrhoea hospitalisation rates were varied according to the upper
and lower limits of the confidence intervals of the respective relative risk [31]. Costs of peer
counselling were varied from US$74 to US$233. The low value was obtained from a scenario
analysis performed in the costing study [15] and the high value from a similar study estimating
the costs of peer counselling in Zambia (data available on request). A range of US$2.2 to US
$6.4 was adopted for costs of HFP, representing the lowest and highest costs identified in the
literature [32, 33].
Probabilistic sensitivity analyses were also undertaken. Beta distributions were fitted for
probability parameters using point estimates and standard errors. Lognormal distributions
were fitted for relative risks using point estimates and their confidence intervals. The gamma
distribution was used for costs and DALYs, with mean costs also representing the standard
error [30].
Statistical analyses
We used Microsoft Excel to summarise cost data, STATA version 11 for statistical analyses and
TreeAge Pro 2012 Suite to model cost effectiveness.
Results
Base case cost-effectiveness
The base case results are presented in Table 4. The costs of breastfeeding promotion were US
$112 for HFP and US$249 for peer counselling, with an incremental cost between the interven-
tions of US$137.
The expected cumulative period of EBF was longer for mothers receiving peer counselling
(3.5 months) than for mothers in the control group who relied on HFP alone (1.5 months)
[28]. The associated incremental effectiveness was two months. The average cost per MEBF
was US$75 for HFP and US$71 for peer counselling, with an incremental cost-effectiveness
ratio of US$68, in favour of peer counselling.
The difference in DALYs averted for HFP and peer counselling was negligible. Irrespective
of intervention, the health loss attributable to morbidity and mortality is about five DALYs per
Cost-Effectiveness of Breastfeeding Promotion
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child, with negligible difference of 0.01 in favour of peer counselling. The incremental cost-
effectiveness ratio of peer counselling is US$11,353 compared to HFP.
Sensitivity analysis
As shown in the tornado diagram in Fig 3, the mortality rate in the intervention group had the
greatest impact, accounting for 49% of the uncertainty, followed by life expectancy (21%), and
cost of treating severe diarrhoea (18%). A further 10% of the variation was accounted for by
the discount rate (9%) and the cost of treating moderate diarrhoea (1%). Varying the other
parameters had little impact on cost-effectiveness.
Results from probabilistic sensitivity analyses are illustrated in Figs 4 and 5. Fig 4 shows the
scatter plot and incremental cost-effectiveness acceptability curve of peer counselling vs HFP
for the MEBF outcome. Fig 4A illustrates how the uncertainty is distributed across both costs
and effectiveness, while Fig 4B, shows that peer counselling has a higher likelihood of being
cost-effective compared to HFP if willingness-to-pay exceeds US$68 per MEBF.
Fig 5 shows the incremental cost-effectiveness scatterplot and acceptability curves of peer
counselling vs HFP for DALYs. The scatter plot (Fig 5A) shows that peer counselling is not
likely to be a cost-effective strategy in averting DALYs. Only 9% of the ICERs in the scatter plot
are cost-effective i.e. fall below a willingness-to-pay threshold of US$1653 per DALY (about 3
times Uganda’s per capita GDP of US$551 [41]). In Fig 5B, it is shown that HFP is more likely
to be cost-effective than peer counselling.
Discussion
This study is the first economic evaluation of a breastfeeding intervention in Uganda and the
second such study in sub-Saharan Africa [17]. Peer counselling is substantially more costly
than standard facility-based services alone, and is only likely to be considered cost-effective if
the willingness-to-pay to increase breastfeeding prevalence exceeds US$68 per MEBF, or US
$11,353 per DALY averted. Uganda has a number of pending maternal and child health inter-
ventions with low coverage that are far more cost-effective.
Results from the PROMISE-EBF trial indicate that there was no association between
increased breastfeeding prevalence and diarrhoea morbidity [11]. It should be noted that even
though we calculated DALYs using trial data, the PROMISE-EBF trial was not powered to
Table 4. Base case results of the cost-effectiveness analysis.
CEA of increasing EBF prevalence
Cost per MEBF
Strategy Cost (US$/Child) IC MEBF/Child IE Cost/MEBF ICER
HFP 113 1.50 75
Peer counselling 250 137 3.50 2.00 71 68
Cost per DALYs averted
Strategy Cost (US$/Child) IC DALY/Child DALYs Cost/DALY ICER
averted
HFP 113 5.76 19
Peer counselling 250 137 5.78 0.01 43 11,353
IC = Incremental cost; IE = Incremental effect; DALYs = Disability adjusted life years; MEBF = Months of EBF; ICER = Incremental cost effectiveness ratio
(IC/IE). US$ = United States Dollars.
doi:10.1371/journal.pone.0142718.t004
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identify an effect of the intervention on mortality. A discussion on these issues is provided else-
where [11].
Study strengths and limitations
Amajor strength of this study is that we primarily use data from a randomised trial, which
minimises selection bias [42]. However, the trial only compared two options: an intervention
and the standard of care. Our economic evaluation therefore only compares a subset of all
available options for promotion of EBF. For example, we did not consider the option of intro-
ducing group counselling, which has also proved to be effective [13].
It was out of the scope of this study to make head-to-head economic comparisons of breast-
feeding promotion and other cost-effective child health interventions such as rotavirus vacci-
nations, diarrhoea management, zinc and vitamin A supplementation [43–45]. Since results
are presented using DALYs averted, comparison is possible across a broad range of disease
Fig 3. Tornado diagram of one-way sensitivity analyses results of uncertain model parameters. EV = expected value. Net health benefits =
((Effectiveness–Costs)/Willingness to pay).
doi:10.1371/journal.pone.0142718.g003
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groups. Cautious priority considerations are therefore possible on a broader basis if the per-
spectives and methods of the different studies are reasonably comparable.
Furthermore, this study only addresses diarrhoea despite evidence that breastfeeding influ-
ences several illnesses, among them acute respiratory infections (ARI), otitis media and juve-
nile diabetes [46, 47]. In addition, mortality is influenced by factors other than feeding practice,
and this was not fully addressed in this study. Our estimates of the cost-effectiveness of EBF
promotion are thus conservative. In addition, we only considered the impact of breastfeeding
for infants up to six months, while some evidence indicate benefits of breastfeeding well into
childhood [48, 49]. This again is likely to underestimate the full effect of breastfeeding promo-
tion interventions, which should be taken into consideration in future evaluations as the empir-
ical evidence improves.
Limited health system cost and disease data for breastfeeding infants meant that we had to
make assumptions about some parameters, especially regarding the transferability of hospitali-
sation and cost data. Data on the costs of different feeding modes from the perspective of the
mothers and families is missing altogether. Since we did not conduct a marginal costing analy-
sis we cannot inform the impact of changing the number of health facility visits, personnel or
other resources that will have to be increased when the intervention is scaled up. Data on costs
of diarrhoea are taken from studies done in other countries, which may have different cost
structures from Uganda. This could underestimate or overestimate the true diarrhoea costs in
Uganda. Comprehensive sensitivity analyses are conducted on this parameter.
Fig 4. Cost-effectiveness scatterplot and acceptability curves for peer counselling vs HFP (Cost/MEBF).
doi:10.1371/journal.pone.0142718.g004
Cost-Effectiveness of Breastfeeding Promotion
PLOS ONE | DOI:10.1371/journal.pone.0142718 November 30, 2015 13 / 18
Comparison with other studies
Our result in terms of cost per MEBF is similar to that found in a South African study [17].
Desmond et al. estimate incremental costs of breastfeeding promotion ranging from US$23 to
US$126 per MEBF, compared to US$68 in our study. The South African intervention was
more intensive, with four home visits to mothers antenatally, compared to one in PROMI-
SE-EBF, and 14 postnatal visits compared to four in our intervention. The mean duration of
EBF in the intervention arm of the South African study was five months [17], compared to 3.5
months in ours [11]. While Desmond and colleagues conclude that EBF promotion through
peer counselling is a cost-effective strategy, we are reluctant to draw this conclusion because
the cost per DALY estimates were not favourable. In separate cost analyses of the PROMI-
SE-EBF trial in South Africa and Uganda, we undertook scenario analyses to show the impact
on unit costs, if the intervention was integrated with primary healthcare. The results showed
that the cost per visit could US$32 in South Africa [16] and US$14 in Uganda [15].
Policy implications
The estimated incremental cost of US$68 per MEBF is more than Uganda’s per capita health
expenditure of US$43 [50]. It is difficult to conclude on the basis of this evidence whether the
intervention is justified, especially since it did not seem to carry any advantages in terms of
Fig 5. Cost-effectiveness scatterplot and acceptability curves for peer counselling vs HFP (Cost/DALY).
doi:10.1371/journal.pone.0142718.g005
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infant growth [51]. This study shows that peer counselling is likely to be the cost-effective strat-
egy for all willingness-to-pay thresholds above US$68 per MEBF.
PROMISE-EBF was a community randomised trial, with more supervision and intensity
than a comparable facility-based intervention. We are uncertain about the impact of scaling up
the intervention to district or even national level over a lengthy period. However, it has been
shown that community strategies may achieve better health outcomes than facility-based strat-
egies, especially in areas with limited health facilities [52].
In the sensitivity analyses, we tested a range of values that were most likely to capture the
extreme changes in parameter estimates. The most sensitive parameter was the mortality rate
in the intervention group, which accounted for 49% of the uncertainty. The other parameters
used in the model were less influential on the cost-effectiveness estimates. This is an important
result, particularly given the scarcity of information in resource poor settings. The model used
in this study can thus be used to make fairly accurate projections on the most probable costs
and consequences of undertaking similar interventions in Uganda and other sub-Saharan Afri-
can countries.
Conclusions
Peer counselling to promote EBF is substantially more expensive than providing advice only
through standard health facility based care. In our study, peer counselling increased both exclu-
sive and predominant breastfeeding prevalence in the first six months. Based on our estima-
tions, peer counselling is not likely to be cost-effective in averting DALYs associated with
diarrhoea. This conclusion may be different in areas where increased EBF prevalence has been
demonstrated to reduce diarrhoea prevalence more than in Uganda or if assessing other mor-
bidity outcomes. We recommend analysis of cost-effectiveness when beneficial effects of the
occurrence also of other illnesses are captured.
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